Corcept Therapeutics Inc (NAQ:CORT) cover image
221 Reads (2 mins read)

Four reasons why the Corcept Therapeutics Inc (NAQ:CORT) share price could move

17th Jun by Ben Hobson

Given widespread disruption and uncertainty in the stock market, it is more important than ever to identify high quality stocks for your portfolio. This means safe, profitable companies with strong balance sheets.

When it comes to investing, it pays to buy and hold the best quality companies possible. What makes these stocks so appealing is their ability to resist competitive threats and generate breathtaking profits. They compound investment returns at consistently above-average rates over the long term.

What makes them different is that they've got what billionaire investor Warren Buffett, calls economic moats.

Here's a quick guide to what makes these stocks stand out - using Corcept Therapeutics Inc (NAQ:CORT) as an example...

GET MORE DATA-DRIVEN INSIGHTS INTO NAQ:CORT »

Has Corcept Therapeutics Inc (NAQ:CORT) got a moat?

When it comes to searching for companies with moats, some of the biggest clues actually lie in their financial statements. By looking at a small number of important ratios you can get an idea about the competitive strength and profit power in a business.

Here's what they are and why they are important - and how Corcept Therapeutics Inc stacks up against them:

  1. High rates of Free Cash Flow - the measure of a thriving company.
    - A high ratio of free cash flow to sales can be a very positive sign. For Corcept Therapeutics Inc, the figure is an impressive 43.2%.
  2. High Return on Capital Employed - the measure of a company growing efficiently and profitably.
    - A 5-year average ROCE of more than 12 percent is a pointer to strong efficiency. For Corcept Therapeutics Inc, the figure is an eye-catching 20.7%.
  3. High Return on Equity (compared to peers) - the measure of a company making good profits from its assets.
    - Corcept Therapeutics Inc has a 5-year average ROE of 28.7%.
  4. High Operating Margins (compared to peers) - the measure of a company with pricing power
    - Corcept Therapeutics Inc has a 5-year average operating margin of 22.2%.

What does this mean for potential investors?

Some of the best quality stocks in the market have defensible models that can deliver high levels of shareholder returns over the long term. But there are no guarantees and it's important to do your own research. Indeed, we've identified some areas of concern with Corcept Therapeutics Inc that you can find out about here.

Alternatively, if you'd like to find more shares that have some of the characteristics of promising economic moats, you should take a look at this Economic Moats screen.

Share this article
As per our Terms of Use, Stockopedia is a financial news & data site, discussion forum and content aggregator. Our site should be used for educational & informational purposes only. We do not provide investment advice, recommendations or views as to whether an investment or strategy is suited to the investment needs of a specific individual. You should make your own decisions and seek independent professional advice before doing so. Remember: Shares can go down as well as up. Past performance is not a guide to future performance & investors may not get back the amount invested.
Share Price
$17.85
Change Today
0.51%
Corcept Therapeutics Inc ( )

Stockopedia is here to help individual investors beat the markets by being the very best in stock analysis, research & community. Take a 30 day free trial of our extensive multi-award winning service and find out why more than ten thousand global investors can't live without it.

© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.